Global Endobronchial Valve Market

Global Endobronchial Valve Market was valued at USD   209.78 Mn in 2025 and is expected to reach USD 310.27 Mn by 2032, growing at a CAGR of 5.75% during the forecast period.

Global Endobronchial Valve Market Overview:

Endobronchial Valve (EBV), is a medical device, which is implanted in an airway in the pulmonary system. These are one-way valves designed to allow air to exit the targeted lung segment without allowing reentry of the inspired air, thus leading to deflation of the emphysematous portion of the lung and volume reduction. Endobronchial valves are typically implanted using a flexible delivery catheter advanced through a bronchoscope, and thus they are minimally invasive.

To Know About The Research Methodology :- Request Free Sample Report

Global Endobronchial Valve Market Dynamics:

Growing awareness regarding procedure for bronchoscopic lung volume reduction in various lung-related diseases is the major factor driving the market.

Prevalence of lung disorders like Chronic Obstructive Pulmonary Disease (COPD) due to increased tobacco smoking worldwide is expected to contribute to the global Endobronchial Valve market growth. Around 65 million people worldwide suffer from COPD. The most common type of COPD is Emphysema, which causes difficulty in breathing and involves damage to the alveoli in the lungs. The growing geriatric population, more susceptible to contracting lung diseases, is expected to propel the market for the Endobronchial valve. The global market for Endobronchial valves is still in the nascent stage. The global Endobronchial valves market is projected to show steady growth as there is no particular substitute available for Endobronchial valves in minimally invasive surgery for lung volume reduction. The high cost associated with surgical procedures and post-operative adhesion issues of the valve may impact negatively market growth.

The report has profiled key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed.

Segment Analysis:

In 2025, the Product Type segment shows the highest demand for Duckbill-shaped Endobronchial Valves. These valves are widely adopted due to their effective one-way airflow control, strong clinical outcomes in lung volume reduction procedures, and ease of bronchoscopic placement. Umbrella-shaped Endobronchial Valves also maintain significant demand, particularly in specific anatomical conditions where their design provides improved anchorage and sealing. While both product types are clinically relevant, duckbill-shaped valves continue to dominate due to broader physician preference and established procedural familiarity.

Based on End-Users, Hospitals represent the largest and most demanded segment in 2025. The dominance of hospitals is driven by the availability of advanced bronchoscopy infrastructure, skilled pulmonologists, and post-procedure monitoring facilities required for endobronchial valve implantation. Ambulatory Surgery Centers are gradually expanding their role due to minimally invasive techniques and shorter recovery times, offering cost-effective procedural settings. Clinical Research Centers contribute steadily to market demand through ongoing trials and innovation in respiratory treatments. However, hospitals remain the primary revenue-generating segment due to higher procedural volumes and patient inflow.

Regional Insights:

Endobronchial Valve Market Scope: Inquire before buying

Global Endobronchial Valve Market, by Region:

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key Players /Competitor Profiles Covered in the Global Endobronchial Valve Market Report from a Strategic Perspective.

1. Pulmonx Corporation
2. Olympus Corporation
3. Boston Scientific Corporation
4. Medtronic plc
5. Teleflex Incorporated
6. Cook Medical
7. Terumo Corporation
8. Ambu A/S
9. Novatech SA
10. Broncus Medical Inc.
11. Spiration Inc.
12. Vyaire Medical Inc.
13. Merit Medical Systems Inc.
14. Micro-Tech Nanjing Co. Ltd.
15. Smiths Medical
16. ENDOFLEX GmbH
17. Intelligent Medical Devices Inc.
18. Harrington Medical
19. Aeris Therapeutics Inc.
20. Emphasys Medical Inc.
21. Xact Robotics Ltd.
22. Vapotherm Inc.
23. Johnson & Johnson
24. Getinge AB
25. Nihon Kohden Corporation